The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nuclear Medicine Diagnostic Equipment Market Research Report 2024

Global Nuclear Medicine Diagnostic Equipment Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1763577

No of Pages : 109

Ask Your Query

Synopsis
Nuclear medicine diagnosis mainly refers to nuclide imaging diagnosis, which can be divided into single photon emission computed tomography (SPECT) and positron emission computed tomography (PET) according to the different ways and types of radioactive elements used to emit gamma photons. Its principle is to inject single-photon/positron radioactive drugs into the human body, and then use SPECT or PET equipment to image the distribution of radionuclides, so as to analyze the function or metabolism of various organs to diagnose diseases. .

Global Nuclear Medicine Diagnostic Equipment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nuclear Medicine Diagnostic Equipment market research.

In terms of the popularity and advancement of the product, SPECT was used clinically before PET, and the penetration rate is higher than that of PET, but the imaging effect of PET is clearer, the radiation damage to the human body is less, and it is more advanced than SPECT. In recent years, the development of PET The market is also growing faster. PET equipment is usually fused with CT and MRI to form PET/CT and PET/MR, and SPECT equipment is usually fused with CT to form SPECT/CT. Separate PET and SPECT equipment have gradually withdrawn from the market.

Currently commonly used medical imaging methods include X-ray imaging, ultrasound imaging, CT, nuclear magnetic resonance MRI, SPECT/CT, PET/CT and PET/MR.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Medicine Diagnostic Equipment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • GE HealthCare
  • Siemens Healthineers
  • Philips
  • Mediso Medical Imaging Systems
  • Digirad
  • Toshiba
  • Compañía Mexicana
  • SurgicEye
  • CMR Naviscan
  • DDD-Diagnostic
  • Positron
  • TeraRecon
  • Neusoft Group
  • United Imaging
  • MinFound Medical
  • SinoUnion Healthcare
  • Top Grade Healthcare

Segment by Type

  • SPECT
  • PET

Segment by Application

  • Tumor Imaging
  • Bone Marrow Imaging
  • Endocrine System Imaging
  • Urinary System Imaging
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Nuclear Medicine Diagnostic Equipment report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Nuclear Medicine Diagnostic Equipment Market Overview
1.1 Product Overview and Scope of Nuclear Medicine Diagnostic Equipment
1.2 Nuclear Medicine Diagnostic Equipment Segment by Type
1.2.1 Global Nuclear Medicine Diagnostic Equipment Market Value Comparison by Type (2023-2029)
1.2.2 SPECT
1.2.3 PET
1.3 Nuclear Medicine Diagnostic Equipment Segment by Application
1.3.1 Global Nuclear Medicine Diagnostic Equipment Market Value by Application: (2023-2029)
1.3.2 Tumor Imaging
1.3.3 Bone Marrow Imaging
1.3.4 Endocrine System Imaging
1.3.5 Urinary System Imaging
1.3.6 Others
1.4 Global Nuclear Medicine Diagnostic Equipment Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine Diagnostic Equipment Revenue 2018-2029
1.4.2 Global Nuclear Medicine Diagnostic Equipment Sales 2018-2029
1.4.3 Global Nuclear Medicine Diagnostic Equipment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nuclear Medicine Diagnostic Equipment Market Competition by Manufacturers
2.1 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nuclear Medicine Diagnostic Equipment Average Price by Manufacturers (2018-2023)
2.4 Global Nuclear Medicine Diagnostic Equipment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nuclear Medicine Diagnostic Equipment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Medicine Diagnostic Equipment, Product Type & Application
2.7 Nuclear Medicine Diagnostic Equipment Market Competitive Situation and Trends
2.7.1 Nuclear Medicine Diagnostic Equipment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nuclear Medicine Diagnostic Equipment Players Market Share by Revenue
2.7.3 Global Nuclear Medicine Diagnostic Equipment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nuclear Medicine Diagnostic Equipment Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine Diagnostic Equipment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nuclear Medicine Diagnostic Equipment Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2018-2029
3.2.1 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2018-2023
3.2.2 Global Nuclear Medicine Diagnostic Equipment Sales by Region: 2024-2029
3.3 Global Nuclear Medicine Diagnostic Equipment Global Nuclear Medicine Diagnostic Equipment Revenue by Region: 2018-2029
3.3.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Region: 2018-2023
3.3.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Region: 2024-2029
3.4 North America Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
3.4.1 North America Nuclear Medicine Diagnostic Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nuclear Medicine Diagnostic Equipment Sales by Country (2018-2029)
3.4.3 North America Nuclear Medicine Diagnostic Equipment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
3.5.1 Europe Nuclear Medicine Diagnostic Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nuclear Medicine Diagnostic Equipment Sales by Country (2018-2029)
3.5.3 Europe Nuclear Medicine Diagnostic Equipment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
3.6.1 Asia Pacific Nuclear Medicine Diagnostic Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nuclear Medicine Diagnostic Equipment Sales by Country (2018-2029)
3.6.3 Asia Pacific Nuclear Medicine Diagnostic Equipment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
3.7.1 Latin America Nuclear Medicine Diagnostic Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nuclear Medicine Diagnostic Equipment Sales by Country (2018-2029)
3.7.3 Latin America Nuclear Medicine Diagnostic Equipment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Medicine Diagnostic Equipment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nuclear Medicine Diagnostic Equipment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nuclear Medicine Diagnostic Equipment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2018-2029)
4.1.1 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2018-2023)
4.1.2 Global Nuclear Medicine Diagnostic Equipment Sales by Type (2024-2029)
4.1.3 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Type (2018-2029)
4.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2018-2029)
4.2.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2018-2023)
4.2.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Type (2024-2029)
4.2.3 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Type (2018-2029)
4.3 Global Nuclear Medicine Diagnostic Equipment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2018-2029)
5.1.1 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2018-2023)
5.1.2 Global Nuclear Medicine Diagnostic Equipment Sales by Application (2024-2029)
5.1.3 Global Nuclear Medicine Diagnostic Equipment Sales Market Share by Application (2018-2029)
5.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2018-2029)
5.2.1 Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2018-2023)
5.2.2 Global Nuclear Medicine Diagnostic Equipment Revenue by Application (2024-2029)
5.2.3 Global Nuclear Medicine Diagnostic Equipment Revenue Market Share by Application (2018-2029)
5.3 Global Nuclear Medicine Diagnostic Equipment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GE HealthCare
6.1.1 GE HealthCare Corporation Information
6.1.2 GE HealthCare Description and Business Overview
6.1.3 GE HealthCare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GE HealthCare Nuclear Medicine Diagnostic Equipment Product Portfolio
6.1.5 GE HealthCare Recent Developments/Updates
6.2 Siemens Healthineers
6.2.1 Siemens Healthineers Corporation Information
6.2.2 Siemens Healthineers Description and Business Overview
6.2.3 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Siemens Healthineers Nuclear Medicine Diagnostic Equipment Product Portfolio
6.2.5 Siemens Healthineers Recent Developments/Updates
6.3 Philips
6.3.1 Philips Corporation Information
6.3.2 Philips Description and Business Overview
6.3.3 Philips Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Philips Nuclear Medicine Diagnostic Equipment Product Portfolio
6.3.5 Philips Recent Developments/Updates
6.4 Mediso Medical Imaging Systems
6.4.1 Mediso Medical Imaging Systems Corporation Information
6.4.2 Mediso Medical Imaging Systems Description and Business Overview
6.4.3 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mediso Medical Imaging Systems Nuclear Medicine Diagnostic Equipment Product Portfolio
6.4.5 Mediso Medical Imaging Systems Recent Developments/Updates
6.5 Digirad
6.5.1 Digirad Corporation Information
6.5.2 Digirad Description and Business Overview
6.5.3 Digirad Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Digirad Nuclear Medicine Diagnostic Equipment Product Portfolio
6.5.5 Digirad Recent Developments/Updates
6.6 Toshiba
6.6.1 Toshiba Corporation Information
6.6.2 Toshiba Description and Business Overview
6.6.3 Toshiba Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Toshiba Nuclear Medicine Diagnostic Equipment Product Portfolio
6.6.5 Toshiba Recent Developments/Updates
6.7 Compañía Mexicana
6.6.1 Compañía Mexicana Corporation Information
6.6.2 Compañía Mexicana Description and Business Overview
6.6.3 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Compañía Mexicana Nuclear Medicine Diagnostic Equipment Product Portfolio
6.7.5 Compañía Mexicana Recent Developments/Updates
6.8 SurgicEye
6.8.1 SurgicEye Corporation Information
6.8.2 SurgicEye Description and Business Overview
6.8.3 SurgicEye Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 SurgicEye Nuclear Medicine Diagnostic Equipment Product Portfolio
6.8.5 SurgicEye Recent Developments/Updates
6.9 CMR Naviscan
6.9.1 CMR Naviscan Corporation Information
6.9.2 CMR Naviscan Description and Business Overview
6.9.3 CMR Naviscan Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 CMR Naviscan Nuclear Medicine Diagnostic Equipment Product Portfolio
6.9.5 CMR Naviscan Recent Developments/Updates
6.10 DDD-Diagnostic
6.10.1 DDD-Diagnostic Corporation Information
6.10.2 DDD-Diagnostic Description and Business Overview
6.10.3 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 DDD-Diagnostic Nuclear Medicine Diagnostic Equipment Product Portfolio
6.10.5 DDD-Diagnostic Recent Developments/Updates
6.11 Positron
6.11.1 Positron Corporation Information
6.11.2 Positron Nuclear Medicine Diagnostic Equipment Description and Business Overview
6.11.3 Positron Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Positron Nuclear Medicine Diagnostic Equipment Product Portfolio
6.11.5 Positron Recent Developments/Updates
6.12 TeraRecon
6.12.1 TeraRecon Corporation Information
6.12.2 TeraRecon Nuclear Medicine Diagnostic Equipment Description and Business Overview
6.12.3 TeraRecon Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 TeraRecon Nuclear Medicine Diagnostic Equipment Product Portfolio
6.12.5 TeraRecon Recent Developments/Updates
6.13 Neusoft Group
6.13.1 Neusoft Group Corporation Information
6.13.2 Neusoft Group Nuclear Medicine Diagnostic Equipment Description and Business Overview
6.13.3 Neusoft Group Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Neusoft Group Nuclear Medicine Diagnostic Equipment Product Portfolio
6.13.5 Neusoft Group Recent Developments/Updates
6.14 United Imaging
6.14.1 United Imaging Corporation Information
6.14.2 United Imaging Nuclear Medicine Diagnostic Equipment Description and Business Overview
6.14.3 United Imaging Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.14.4 United Imaging Nuclear Medicine Diagnostic Equipment Product Portfolio
6.14.5 United Imaging Recent Developments/Updates
6.15 MinFound Medical
6.15.1 MinFound Medical Corporation Information
6.15.2 MinFound Medical Nuclear Medicine Diagnostic Equipment Description and Business Overview
6.15.3 MinFound Medical Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.15.4 MinFound Medical Nuclear Medicine Diagnostic Equipment Product Portfolio
6.15.5 MinFound Medical Recent Developments/Updates
6.16 SinoUnion Healthcare
6.16.1 SinoUnion Healthcare Corporation Information
6.16.2 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Description and Business Overview
6.16.3 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.16.4 SinoUnion Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
6.16.5 SinoUnion Healthcare Recent Developments/Updates
6.17 Top Grade Healthcare
6.17.1 Top Grade Healthcare Corporation Information
6.17.2 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Description and Business Overview
6.17.3 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Top Grade Healthcare Nuclear Medicine Diagnostic Equipment Product Portfolio
6.17.5 Top Grade Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Medicine Diagnostic Equipment Industry Chain Analysis
7.2 Nuclear Medicine Diagnostic Equipment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Medicine Diagnostic Equipment Production Mode & Process
7.4 Nuclear Medicine Diagnostic Equipment Sales and Marketing
7.4.1 Nuclear Medicine Diagnostic Equipment Sales Channels
7.4.2 Nuclear Medicine Diagnostic Equipment Distributors
7.5 Nuclear Medicine Diagnostic Equipment Customers
8 Nuclear Medicine Diagnostic Equipment Market Dynamics
8.1 Nuclear Medicine Diagnostic Equipment Industry Trends
8.2 Nuclear Medicine Diagnostic Equipment Market Drivers
8.3 Nuclear Medicine Diagnostic Equipment Market Challenges
8.4 Nuclear Medicine Diagnostic Equipment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock